SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer

Company Leadership Changes - Ross Muken has been promoted to President of SOPHiA GENETICS, effective November 5, 2024, overseeing global business operations and strategic planning alongside CEO Jurgi Camblong [1][2] - George Cardoza has been appointed as the new CFO, responsible for all corporate finance functions including accounting, financial planning and analysis, investor relations, internal audit, tax, and treasury [2][3] Executive Backgrounds - Ross Muken joined SOPHiA GENETICS in February 2021 as CFO and became CFO and COO in March 2023, playing a key role in the company's success [1][2] - George Cardoza brings over 30 years of experience in the precision medicine and clinical diagnostics industry, having held executive roles at Biocartis and NeoGenomics Laboratories [3][4] Company Mission and Technology - SOPHiA GENETICS is a cloud-native healthcare technology company focused on expanding access to data-driven medicine using AI to provide care for patients with cancer and rare disorders [5] - The company developed SOPHiA DDM™, a platform that analyzes complex genomic and multimodal data to generate actionable insights for hospitals, laboratories, and biopharma institutions [5]